CRP and hepatocellular carcinoma: LS-based prediction paradigms have also been proposed: Shin et al. designed a model for HCC prediction in HBV patients considering LS, spleen diameter, and platelet count [54], and Liu et al. reported the role of C-reactive protein in improving LS prognostic role for HCC onset in HBV-related cirrhosis [55].